| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UKNOWN |
| UNII: | C98V9UMX3D |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | IgG receptor FcRn large subunit p51 inhibitor | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Myasthenia Gravis | 2 | D009157 | ClinicalTrials |
| Purpura, Thrombocytopenic, Idiopathic | 2 | D016553 | ClinicalTrials |
| Anemia, Hemolytic, Autoimmune | 2 | D000744 | ClinicalTrials |
| Graves Ophthalmopathy | 2 | D049970 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4650514 |
| FDA SRS | C98V9UMX3D |
CONTENTS